Browsing by Author Sumitra Thongprasert

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 31 to 34 of 34 < previous 
Issue DateTitleAuthor(s)
26-Sep-2015Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 StudyJohan F. Vansteenkiste; Jean Luc Canon; Filippo De Braud; Francesco Grossi; Tommaso De Pas; Jhanelle E. Gray; Wu Chou Su; Enriqueta Felip; Hiroshige Yoshioka; Cesare Gridelli; Grace K. Dy; Sumitra Thongprasert; Martin Reck; Paola Aimone; Gena Atalla Vidam; Pantelia Roussou; Ying A. Wang; Emmanuelle Di Tomaso; Jean Charles Soria
10-Jun-2012Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: A phase III trialGiorgio V. Scagliotti; Maciej Krzakowski; Aleksandra Szczesna; Janos Strausz; Anatoly Makhson; Martin Reck; Rafal F. Wierzbicki; Istvan Albert; Michael Thomas; Jose Elias Abrao Miziara; Zsolt S. Papai; Nina Karaseva; Sumitra Thongprasert; Elsa Dalmau Portulas; Joachim Von Pawel; Ke Zhang; Paulina Selaru; Lesley Tye; Richard C. Chao; Ramaswamy Govindan
1-Aug-2016Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancerTony Mok; Guia Ladrera; Vichien Srimuninnimit; Virote Sriuranpong; Chong Jen Yu; Sumitra Thongprasert; Jennifer Sandoval-Tan; Jin Soo Lee; Fatima Fuerte; David S. Shames; Barbara Klughammer; Matt Truman; Pablo Perez-Moreno; Yi Long Wu
1-Aug-2013Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS studyYi Long Wu; Masahiro Fukuoka; Tony S.K. Mok; Nagahiro Saijo; Sumitra Thongprasert; James C.H. Yang; Da Tong Chu; Jin Ji Yang; Yuri Rukazenkov